Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Trading Statement

12 Oct 2007 07:00

Cyprotex PLC12 October 2007 Cyprotex PLC (the "Group" or "Cyprotex") NEWS 12 October 2007 Trading Update : Building Confidence The Director's confidence with Cyprotex's core operations continued to buildduring the third quarter of 2007. The Group enters the final three months ofits year on an optimistic note. Historically the final quarter has been the strongest period of Cyprotex'sfinancial year. Moreover, management is pleased to confirm that its customerbase has continued to expand rapidly. Included within the high number of newMSA (Master Services Agreements) recently signed, and taking the Group's 'activecustomer list' beyond 150 pharmaceutical and biotech companies, are severalinternational majors. Strict confidentiality agreements preclude Cyprotex fromnaming individual clients, but the company can now confirm it is currentlycontracted to work for six out of the world's 'top ten' global pharmaceuticalcompanies. The scale and visibility that strong working relationships with suchpartners are capable of providing, is key to proving Cyprotex's business plan.The management is pleased to report an exceptional level of repeat business,while also being asked to tenders for more long-term contract work as well asproject specific collaborations. Cyprotex presently holds an adequate cash resource whilst also retaining asignificant, unused banking facility. Based on current momentum, managementsees the opportunity for modest cash generation to expand this 'cushion' stillfurther during the final three months of the 2007. For further information: Cyprotex PLCRobert Morrison Atwater, CEORussell Gibbs, CFOTel: +44 (0)1625 505 100ir@cyprotex.comwww.cyprotex.com Numura Code Securities LimitedCharles Walker, Corporate FinanceTel: +44 (0)20 7776 1200cew@nomuracode.comwww.nomuracode.com Media Enquires: WMC CommunicationsSimon MillerTel: +44 (0)20 7930 9030simon.miller@wmccommunications.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Oct 20169:03 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
7th Oct 20169:36 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
6th Oct 20165:15 pmRNSConversion of Loan Notes & TVR
6th Oct 20167:00 amRNSNew DDI-Fusion
5th Oct 20169:11 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
3rd Oct 20169:50 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
30th Sep 20169:26 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
29th Sep 20169:42 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
27th Sep 20169:34 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
26th Sep 201610:02 amRNSForm 8.3 - Cyprotex Plc
26th Sep 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
26th Sep 20167:00 amRNSAppointment of new Director of US Operations
23rd Sep 20169:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
21st Sep 20169:29 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
20th Sep 20169:09 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
19th Sep 20169:42 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
16th Sep 20163:52 pmRNSForm 8.3 - Cyprotex plc
16th Sep 20169:36 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
15th Sep 201610:33 amRNSForm 8.3 - Cyprotex plc
15th Sep 201610:05 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th Sep 20169:33 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th Sep 20167:00 amRNSExtension of metabolite identification service
12th Sep 201612:31 pmRNSForm 8.3 - Cyprotex plc
9th Sep 20169:15 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
8th Sep 20167:00 amRNSExpansion ADME capabilities (8 transporter assays)
7th Sep 20169:43 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
6th Sep 201610:08 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
2nd Sep 20169:12 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
1st Sep 20169:31 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
31st Aug 20169:47 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
30th Aug 20169:28 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
26th Aug 20169:34 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
25th Aug 20169:39 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
25th Aug 20167:00 amRNSInstallation of two mass spectrometer systems
23rd Aug 20169:39 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
22nd Aug 201610:01 amRNSForm 8.5 (EPT/RI)
17th Aug 201611:24 amRNSForm 8.3 - Cyptotex Plc
17th Aug 20169:39 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
16th Aug 20169:25 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
15th Aug 201610:52 amRNSForm 8.3 - Cyprotex Plc
15th Aug 20169:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
12th Aug 20169:29 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th Aug 20169:15 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
10th Aug 201611:14 amRNSForm 8.3 - Cyprotex Plc
10th Aug 20169:14 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
9th Aug 20169:14 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
8th Aug 201611:10 amRNSForm 8.3 - Cyprotex
8th Aug 20169:29 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
5th Aug 201611:00 amRNSForm 8.3 - Cyprotex Plc
5th Aug 20169:32 amRNSForm 8.3 - Cyprotex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.